L152-0106 Screening compound: 5-[(4-CHLOROPHENYL)METHYL]-7-METHYL-4-OXO-N-[2-(THIOPHEN-2-YL)ETHYL]-4H,5H-[1,2,4]TRIAZOLO[1,5-A]QUINOXALINE-2-CARBOXAMIDE

L152-0106 Screening compound: 5-[(4-CHLOROPHENYL)METHYL]-7-METHYL-4-OXO-N-[2-(THIOPHEN-2-YL)ETHYL]-4H,5H-[1,2,4]TRIAZOLO[1,5-A]QUINOXALINE-2-CARBOXAMIDE
L152-0106 Screening compound: 5-[(4-CHLOROPHENYL)METHYL]-7-METHYL-4-OXO-N-[2-(THIOPHEN-2-YL)ETHYL]-4H,5H-[1,2,4]TRIAZOLO[1,5-A]QUINOXALINE-2-CARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound L152-0106
5-[(4-CHLOROPHENYL)METHYL]-7-METHYL-4-OXO-N-[2-(THIOPHEN-2-YL)ETHYL]-4H,5H-[1,2,4]TRIAZOLO[1,5-A]QUINOXALINE-2-CARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L152-0106

Molecular Formula

C24H20ClN5O2S (C24 H20 ClN5 O2 S)

Compound Name

5-[(4-CHLOROPHENYL)METHYL]-7-METHYL-4-OXO-N-[2-(THIOPHEN-2-YL)ETHYL]-4H,5H-[1,2,4]TRIAZOLO[1,5-A]QUINOXALINE-2-CARBOXAMIDE

IUPAC name

n/a

SMILES

Cc(cc1)cc(N2Cc(cc3)ccc3Cl)c1-n1nc(C(NCCc3cccs3)=O)nc1C2=O

InChI

InChI=1S/C24H20ClN5O2S/c1-15-4-9-19-20(13-15)29(14-16-5-7-17(25)8-6-16)24(32)22-27-21(28-30(19)22)23(31)26-11-10-18-3-2-12-33-18/h2-9,12-13H,10-11,14H2,1H3,(H,26,31)

InChI Key

RCNXVOUMMAEWSV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15119624

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

477.97

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.543

Distribution Coefficient, logD

4.543

Water Solubility, LogSw

-4.65

Polar Surface Area

63.896

Acid Dissociation Constant (pKa)

13.13

Base Dissociation Constant (pKb)

-5.52

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

16.70

L152-0106 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Angiogenesis library (14822 compounds)

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

New Agro Library (44492 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Antiviral
  • Infections
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
Agro:
  • Agro

References: we are preparing a list of scientific research reports with L152-0106 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L152-0106?
Check Price and Availability of L152-0106, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L152-0106 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L152-0106
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L152-0106
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L152-0106 available by request